ONCE-YEARLY ZOLEDRONIC ACID 5 MG INFUSION FOR TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: EFFECTS ON FRACTURE INCIDENCE IN PATIENT SUBGROUPS FROM THE HORIZON-PFT STUDY

被引：0
|
作者：
Eastell, Richard [1 ]
Black, Dennis M. [3 ]
Boonen, Steven [2 ]
McLellan, Alastair R. [4 ]
Cummings, Steven R. [3 ]
Delmas, Pierre D. [5 ,6 ]
Palermo, Lisa [3 ]
Mesenbrink, Peter [7 ]
Cauley, Jane A. [8 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Katholieke Univ Leuven, Leuven, Belgium
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
[5] INSERM, Res U831, F-69008 Lyon, France
[6] Univ Lyon, Lyon, France
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Univ Pittsburgh, Pittsburgh, PA USA
来源：
RHEUMATOLOGY | 2009年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I105 / I105
页数：1
相关论文
共 50 条
  • [21] Effect of zoledronic acid 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-pft
    Cauley, J.
    Black, D.
    Boonen, S.
    Cummings, S.
    Delmas, P.
    Eriksen, E. F.
    Hu, H.
    Eastell, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
  • [22] Effect of zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-PFT
    Cauley, Jane A.
    Black, Dennis
    Boonen, Steven R.
    Cummings, Steven
    Delmas, Pierre
    Eastell, Richard
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S232 - S232
  • [23] Effect of Zoledronic Acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: results from HORIZON-PFT
    Cauley, J.
    Black, D.
    Boonen, S.
    Cummings, S.
    Delmas, P.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S26 - S26
  • [24] Effect of zoledronic acid (ZOL) 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-PFT
    Cauley, J. A.
    Adachi, J.
    Cosman, F.
    Black, D.
    Boonen, S. R.
    Cummings, S.
    Delmas, P.
    Eastell, R.
    BONE, 2007, 40 (06) : S132 - S132
  • [25] The Addition of Once-Yearly Zoledronic Acid 5mg to Non-Bisphosphonate Treatment for Osteoporosis Reduced Fractures in Postmenopausal Women: The Horizon-Pivotal Fracture Trial
    Reid, David
    Delmas, Pierre
    Eastell, Richard
    Boonen, Steven
    Cummings, Steven
    Palermo, Lisa
    Cauley, Jane
    Recknor, Chris
    Cosman, Felicia
    Mesenbrink, Peter
    Krieginan, Andrey
    Eriksen, Erik
    Black, Dennis
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1204 - 1205
  • [26] Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
    Jacques, Richard M.
    Boonen, Steven
    Cosman, Felicia
    Reid, Ian R.
    Bauer, Douglas C.
    Black, Dennis M.
    Eastell, Richard
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (08) : 1627 - 1634
  • [27] RENAL EFFECTS OF TREATMENT WITH ZOLEDRONIC ACID: RESULTS FROM THE HORIZON-PFT EXTENSION STUDY
    Miller, Paul D.
    Black, Dennis M.
    Hruska, Josef
    Boonen, Steven
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S197 - S198
  • [28] HORIZON: Yearly infusion of zoledronic acid reduces risk of fracture in postmenopausal women with osteoporosis
    不详
    FORMULARY, 2007, 42 (08) : 488 - 489
  • [29] Increased integral bone mineral density (BMD) of the hip with once-yearly zoledronic acid 5 mg (ZOL): Quantitative computed tomography data (QCT) from the horizon-pft trial
    Eastell, R.
    Lang, T.
    Boonen, S.
    Cummings, S.
    Delmas, P. D.
    Cauley, J.
    Horowitz, Z.
    Kerzberg, E.
    Leung, P.
    Man, Z.
    Mesenbrink, P.
    Eriksen, E. F.
    Black, D.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S54 - S55
  • [30] Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older
    Boonen, Steven
    Black, Dennis M.
    Colon-Emeric, Cathleen S.
    Eastell, Richard
    Magaziner, Jay S.
    Eriksen, Erik Fink
    Mesenbrink, Peter
    Haentjens, Patrick
    Lyles, Kenneth W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (02) : 292 - 299
12345